BT
biote Corp.
BTMD · NASDAQ
$1.33 -1.85% (-$0.03)
1M -15.29%
Market Cap $58.4M
P/E Ratio 9.98x
Div. Yield -
ROE -
Bulios Fair Price
$1.42
7.2% upside
Current Price
$1.33
Undervalued Fair Value Overvalued
According to Bulios Fair Price, BTMD is currently undervalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Strong
7/9Valuation
99 /100
Cheap P/FCF 2.97x
P/S 0.32x
P/E 9.98x
Growth
71 /100
Growing Rev. growth 5.23%
EPS growth 66.61%
Book val. growth N/A
Profitability
56 /100
Moderate FCF margin 10.72%
Op. margin 8.04%
Gross margin 60.23%
Quality
75 /100
Excellent ROA 5.76%
Asset turnover 1.80x
ROIC 13.50%
Debt
26 /100
High Int. coverage 2.10x
Net debt/EBITDA 5.01x
Current ratio 1.43x
Stability
44 /100
Moderate Profitable years 3
EPS volatility 420.01%
Beta 1.61x
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about BTMD
Online
Sector
Healthcare
Industry
Medical - Care Facilities
CEO
Robert C. Peterson
Employees
223
Headquarters
Irving
Upcoming events
04 NOV
Earnings
Upcoming earnings report